<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Markus Diefenhardt | MLO Lab</title><link>https://mlo-lab.github.io/author/markus-diefenhardt/</link><atom:link href="https://mlo-lab.github.io/author/markus-diefenhardt/index.xml" rel="self" type="application/rss+xml"/><description>Markus Diefenhardt</description><generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><copyright>Â© 2024 MLO Lab</copyright><lastBuildDate>Sat, 01 Jan 2022 00:00:00 +0000</lastBuildDate><image><url>https://mlo-lab.github.io/media/logo_huf4d7cfef1565109ab26b35fe95d2b8f5_47080_300x300_fit_lanczos_2.png</url><title>Markus Diefenhardt</title><link>https://mlo-lab.github.io/author/markus-diefenhardt/</link></image><item><title>Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer</title><link>https://mlo-lab.github.io/publication/nicolas-2022-inflammatory/</link><pubDate>Sat, 01 Jan 2022 00:00:00 +0000</pubDate><guid>https://mlo-lab.github.io/publication/nicolas-2022-inflammatory/</guid><description/></item></channel></rss>